Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management
- 1 December 1998
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 98 (s393) , 95-101
- https://doi.org/10.1111/j.1600-0447.1998.tb05973.x
Abstract
The treatment of anxiety has evolved through various phases. Currently, there is a growing recognition that anxiety disorders are frequently chronic and/or recurrent. There is also less optimism than a decade ago that benzodiazepines will be replaced by alternative agents that are not active at the benzodiazepine receptor. Consequently, the understanding and management of benzodiazepine dependence and withdrawal continue to be of some clinical importance. This article briefly reviews the withdrawal syndrome and the pharmacological and patient variables that contribute to it. It then summarizes the various approaches to managing benzodiazepine dependence and withdrawal.Keywords
This publication has 36 references indexed in Scilit:
- Biological function of GABAA/benzodiazepine receptor heterogeneityJournal of Psychiatric Research, 1995
- Assessment of the Efficacy of Buspirone in Patients Affected by Generalized Anxiety Disorder, Shifting to Buspirone From Prior Treatment with LorazepamJournal of Clinical Psychopharmacology, 1995
- A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptomsInternational Clinical Psychopharmacology, 1993
- Consequences of the 1989 New York State triplicate benzodiazepine prescription regulationsPublished by American Medical Association (AMA) ,1991
- Chronic Benzodiazepine DependenceThe British Journal of Psychiatry, 1990
- Blood Pressure and Blood Pressure Variability Following Withdrawal of Propranolol and ClonidineThe Journal of Clinical Pharmacology, 1989
- FLUMAZENIL: A POSSIBLE TREATMENT FOR BENZODIAZEPINE WITHDRAWAL ANXIETYThe Lancet, 1987
- Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA ReceptorScience, 1986
- BENZODIAZEPINE WITHDRAWAL SYMPTOMS AND PROPRANOLOLThe Lancet, 1981
- LENGTH OF TREATMENT WITH ANXIOLYTIC SEDATIVES AND RESPONSE TO THEIR SUDDEN WITHDRAWALActa Psychiatrica Scandinavica, 1973